Efficacy and safety of visepegenatide as an add-on therapy to metformin in patients with type 2 diabetes: a randomised, double-blind, parallel, placebo-controlled, phase 3 study
维塞培根肽作为二甲双胍辅助治疗药物在2型糖尿病患者中的疗效和安全性:一项随机、双盲、平行、安慰剂对照的3期研究
期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2024.101197
Cai, Xiaoling; Ji, Linong; Yuan, Mingxia; Ma, Jianhua; Bian, Fang; Li, Sheli; Pang, Wuyan; Yan, Shuang; Zhou, Huimin; Hou, Minghui; Li, Wenhui; Jia, Ying; Liu, Li; Ding, Ke; Xu, Michael